| News

ten23 health settles in Basel

02.09.2021

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health. As a partner, it hopes to support leading global biotech and pharma clients with the development, manufacture, and testing of injectable biopharmaceuticals.

Ten23 health has announced that it has commenced operations in Basel. Its company headquarters are located on the Rosental Mitte campus. A new working environment for 150 full-time positions is being offered over 4,000 square meters of laboratory and office space in the building that was formerly home to Elanco.

The company hopes to use its scientific competence and its “globally recognized” expertise in industry and regulations to support clients from the global biotech and pharmaceutical industries with the development, manufacture, and testing of injectable biopharmaceuticals. It is “solidly financed” through the commitment of the UK-based associated company 3i Group.

Ten23 health states that it is led by a world-class leadership team and is able to demonstrate “outstanding expertise” in the biopharmaceutical industry, pharmaceutical and analytical sciences, development, and regulatory requirements. The team headed up by CEO Prof. Dr. Hanns-Christian Mahler has “a proven track record in the field of pharmaceutical product design and development” as well as an “extensive global pharma network”.

The CEO adds: “Our comprehensive offering will allow our clients to focus on the medicine and the patient, whilst leveraging our pharmaceutical expertise and knowledge to plan and de-risk product development.” The aim is to enable rapid, high-quality, successful commercialization.

Richard Relyea, a Partner at 3i and a Member of the Board of Directors of ten23 health, emphasizes the holistic approach of ten23 health, saying: “We will deliver services in an engrained, fair and sustainable manner.” By investing in ten23 health, 3i intends to support “the establishment of a uniquely differentiated partner to leading global biotech and pharmaceutical customers”.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Ontotext opens new office in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Ontotext opens new office in the Basel Area

Ontotext, a company based in New York City and the Bulgarian capital of Sofia, has opened a new location at...

Read More
Owkin heads to Basel
Basel Area Business & Innovation, Innovation, Invest

Owkin heads to Basel

The Franco-US startup Owkin is establishing a branch office in Basel. The company develops solutions for the life sciences industry...

Read More
Danish AI company settling in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Danish AI company settling in the Basel Area

Abzu has settled on the Novartis Campus of the Switzerland Innovation Park Basel Area. From there, the Danish deep tech...

Read More
«I always wanted to create something from scratch»
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

«I always wanted to create something from scratch»

Already when he was young, he was driven to create and invent. Today at the age of 33, Gwenael Hannema...

Read More
The i4Challenge announces the winners of 2021
Basel Area Business & Innovation, Innovation

The i4Challenge announces the winners of 2021

The i4Challenge shines a light on companies and innovators who help to facilitate the industrial transformation. We present the winners...

Read More
Basel Area becomes the Swiss hotspot for Chinese pharma companies
Basel Area Business & Innovation, Innovation, Invest

Basel Area becomes the Swiss hotspot for Chinese pharma companies

More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them...

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.